KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

Teva Pharmaceutical Industries (TEVA) Amortization - Goodwill (2016 - 2024)

Historic Amortization - Goodwill for Teva Pharmaceutical Industries (TEVA) over the last 7 years, with Q4 2024 value amounting to $280.0 million.

  • Teva Pharmaceutical Industries' Amortization - Goodwill changed N/A to $280.0 million in Q4 2024 from the same period last year, while for Dec 2025 it was $280.0 million, marking a year-over-year decrease of 7812.5%. This contributed to the annual value of $1.3 billion for FY2024, which is 8285.71% up from last year.
  • According to the latest figures from Q4 2024, Teva Pharmaceutical Industries' Amortization - Goodwill is $280.0 million.
  • Teva Pharmaceutical Industries' Amortization - Goodwill's 5-year high stood at $4.6 billion during Q3 2020, with a 5-year trough of $280.0 million in Q4 2024.
  • Moreover, its 4-year median value for Amortization - Goodwill was $700.0 million (2023), whereas its average is $1.2 billion.
  • Its Amortization - Goodwill has fluctuated over the past 5 years, first crashed by 604.03% in 2023, then tumbled by 4285.71% in 2024.
  • Quarter analysis of 4 years shows Teva Pharmaceutical Industries' Amortization - Goodwill stood at $4.6 billion in 2020, then tumbled by 71.91% to $1.3 billion in 2022, then crashed by 46.15% to $700.0 million in 2023, then tumbled by 60.0% to $280.0 million in 2024.
  • Its Amortization - Goodwill stands at $280.0 million for Q4 2024, versus $600.0 million for Q3 2024 and $400.0 million for Q2 2024.